Inventor · Cambridge, MA, US

Li Zhou

22Patents
5h-index
65Co-inventors
68Inventor score

Filing activity: May 5, 2011 → Sep 23, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US10287354B2 Regulatable chimeric antigen receptor Chemistry; Metallurgy 21 Active
US10253086B2 CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell Chemistry; Metallurgy 20 Active
US9290573B2 Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies Chemistry; Metallurgy 16 Active
US8883735B2 Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs Emerging Cross-Sectional Technologies 7 Active
US11149076B2 CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell Chemistry; Metallurgy 5 Active
US11175289B2 Application of TRPM8 protein, related peptide fragment and their antibodies Physics 1 Active
US9173960B2 Methods of treating cancer with low density lipoprotein-related protein 6 (LRP6)—half life extender constructs Emerging Cross-Sectional Technologies 1 Active
US11578130B2 Regulatable chimeric antigen receptor Chemistry; Metallurgy 0 Active
US9896679B2 Fused NHase with improved specific activity and stability Chemistry; Metallurgy 0 Active
US11760988B2 L-aspartate alpha-decarboxylase mutant and application thereof Chemistry; Metallurgy 0 Active
US12312402B2 Antibody or chimeric antigen receptor which targets Claudin 18.2 Physics 0 Active
US11814432B2 Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof Chemistry; Metallurgy 0 Active
USRE47860E1 Methods of treating cancer with low density lipoprotein-related protein 6 (LRP6)—half life extender constructs General 0 Active
US9670474B2 Fused NHase with improved specific activity and stability Chemistry; Metallurgy 0 Active
US10837036B2 Method for preparing L-aspartic acid with maleic acid by whole-cell biocatalysis Chemistry; Metallurgy 0 Active
US12098373B2 Bacillus subtilis efficiently-induced expression system based on artificial series promoter Chemistry; Metallurgy 0 Active
US12123007B2 Method for constructing efficient Bacillus subtilis promoter Chemistry; Metallurgy 0 Active
US12031165B2 Double enzyme tandem preparation method of l-2-aminobutyric acid Chemistry; Metallurgy 0 Active
US12319941B2 Thermophilic recombinant type II pullulanase and application thereof Chemistry; Metallurgy 0 Active
US12344657B2 CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell Chemistry; Metallurgy 0 Active
US12104189B2 Mutant of nitrile hydratase derived from Caldalkalibacillus thermarum Chemistry; Metallurgy 0 Active
US11332731B2 Nitrile hydratase mutant, genetically engineered bacterium containing mutant and applications thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.